【摘要】 目的:探讨微创穿刺治疗幕上高血压脑出血(HICH)的手术时机与疗效。方法:回顾性分析2008年3月至2011年3月广东省河源市人民医院收治的92例血肿量为30～60 mL的幕上HICH患者的临床资料,患者均行微创穿刺配合尿激酶液化引流术,根据发病至治疗时间不同分为A组44例(脑出血时间≤6 h)和B组48例(脑出血时间6～24 h),比较两组患者的再出血率、病死率和痊愈率。结果:两组患者再出血率、病死率比较,差别无统计学意义(P>0.05);A组患者的痊愈率为85.4%,高于B组的65.2%(P<0.05)。结论:超早期微创穿刺配合尿激酶液化引流术治疗血肿量为30～60 mL的幕上HICH安全、有效。更多还原

【Abstract】 Objective:To explore the time for initiation and efficacy of minimally invasive neurosurgery for supratentorial hypertensive intracerebral hemorrhage(HICH).Methods:We did a retrospective analysis on the clinical profiles of 92 patients with supratentorial HICH(30-60 ml) admitted to Heyuan People’s Hospital between March 2008 and March 2011.All patients were treated with minimally invasive neurosurgery in combination with urokinase liquefied drainage and were assigned to group A(n = 44,≤6 hrs) and group B(n =48,6-24 hrs),based on the duration from disease onset to treatment intervention.The incidence of recurrent hemorrhage,mortality and rate of recovery were compared.Results:Both groups did not differ statistically in the incidence of recurrent hemorrhage and mortality(P>0.05 ).Higher rate of recovery was in favor of group A(85.4%),but not in group B(65. 2%,P<0.05).Conclusion:The combination of urokinase liquefied drainage and minimally invasive neurosurgery at the ultra - early stage may be effective and safe for the treatment of HICH with hematoma(30 -60 ml).更多还原